TickerFacts.

OneMedNet Corp (ONMD): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.86M
Year ended 2025-12-31
$2.67M
Trailing 12 months to 2026-06-30
+7.2%
3-year compound annual growth
2022-12-31: $1.51M2023-12-31: $1.15M2024-12-31: $924.0K2025-12-31: $1.86M$1.86M
2022-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$1.86M+101.5%2026-03-30, From 2025-01-01
2024-12-31$924.0K-19.7%2026-03-30, From 2024-01-01
2023-12-31$1.15M-24.0%2025-04-15, From 2023-01-01
2022-12-31$1.51Mn/a2024-11-05, From 2022-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
OneMedNet Corp (ONMD)2025-12-31$1.86M+101.5%
iSpecimen Inc. (ISPC)2025-12-31$1.90M-64.1%
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$40.1K-12.0%
MaxCyte, Inc. (MXCT)2025-12-31$6.22M-12.4%
Incyte Corp (INCY)2025-12-31$372.13M+19.2%
Icon PLC (ICLR)2024-12-31$5.85B+2.2%
Weed, Inc. (BUDZ)2025-12-31$0n/a
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0n/a

Compare ONMD, ISPC, CBIH, MXCT side by side · Screen every company in Services-Commercial Physical & Biological Research ↗